Purpose: Minimally invasive surgery for parathyroid adenomas (PTA) requires precise identification and localization of the diseased gland prior to exploration for optimal surgical planning. The Perrier classification allows for accurate, reproducible, and reliable description of PTA location and communication of clinically significant information to surgeons. The current study compares the Perrier localization of PTA on [Tc]methoxyisobutylisonitrile ([Tc]MIBI) single-photon emission computed tomography (SPECT)/X-ray computed tomography (CT) with the results of surgery.

Procedures: Eighty-eight patients (60 females), age 13-82 years, with primary hyperparathyroidism underwent [Tc]MIBI SPECT/CT prior to surgery. Eight patients had parathyroid hyperplasia and underwent excision of 3.5 parathyroid glands, including five patients with a negative [Tc]MIBI study and three patients with multiple foci of uptake, and were excluded from further analysis. Each PTA was localized to Perrier levels A-G. The surgeon located each PTA found on surgery using the same classification. PTA localization on SPECT/CT and at surgery was compared.

Results: Eighty patients with surgically confirmed PTA were analyzed. On [Tc]MIBI SPECT/CT, 63 patients had a single and one patient had two PTAs for a total of 65 PTAs. At surgery, 85 PTAs were resected in 80 patients, including 75 patients with single and 5 with two PTAs. Twenty PTAs found on surgery were not detected on [Tc]MIBI. The relatively lower weight of these 20 PTAs is probably the main reason for the false-negative results group. The same Perrier localization was determined on SPECT/CT and surgery in 52/65 PTAs (80 %). In the 13 incongruent cases, the PTAs were localized at different locations but on the same side of the thyroid gland.

Conclusions: [Tc]MIBI SPECT/CT accurately localized a PTA according to the Perrier classification in 80 % of cases. Reporting SPECT/CT results using anatomy-based PTA localization criteria accepted by surgeons can contribute significantly towards better interspecialty communication and will improve performance of minimally invasive surgical removal of PTAs.

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11307-016-1013-2DOI Listing

Publication Analysis

Top Keywords

[tc]mibi spect/ct
16
pta
9
ptas
9
minimally invasive
8
perrier classification
8
perrier localization
8
computed tomography
8
patients
8
including patients
8
pta localization
8

Similar Publications

Purpose: Parathyroid carcinoma (PC) is an extremely rare disease, typically presenting with marked elevations of serum calcium concentrations and associated with significantly increased parathyroid hormone (PTH) levels. Although it progresses slowly, approximately25% of PC patients have lung metastases. In the present study, we aimed to evaluate the role of technetium-99m methoxy isobutyl isonitrile (Tc-99m-MIBI; sestamibi) SPECT/CT scintigraphy in the preoperative localization of parathyroid adenomas, incidental metastases findings of PC, and ectopic parathyroid tissue.

View Article and Find Full Text PDF

Localization in primary hyperparathyroidism.

Best Pract Res Clin Endocrinol Metab

December 2024

Department of Nuclear Medicine, Post Graduate Institute of Medical Education and Research, Sector 12, Chandigarh 160012, India. Electronic address:

Primary hyperparathyroidism is the main cause of hypercalcemia, resulting predominantly from parathyroid adenomas followed by hyperplasia. Diagnosis relies on clinical and biochemical parameters. Accurate pre-operative localization is mandatory for better surgical outcome.

View Article and Find Full Text PDF
Article Synopsis
  • - Minimally invasive parathyroidectomy is the preferred treatment for primary hyperparathyroidism, but it relies on effective preoperative localization methods to identify overactive parathyroid tissue.
  • - A study compared two groups of patients—234 who had traditional MIBI scintigraphy and 163 who had FCh-PET/CT—focusing on the efficiency and outcomes of these imaging techniques leading up to surgery.
  • - Results showed that FCh-PET/CT significantly reduced imaging time by 83% and surgery time by 41% without using intraoperative hormone monitoring, suggesting it may lead to faster procedures and fewer reoperations for patients.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!